MediPharm Labs, a specialized, research-driven company focused on pharmaceutical-quality cannabis extraction and cannabis based health products, is announcing that President and Co-Founder Keith Strachan will be stepping down from his management position effective December 31, 2024. Keith will continue to provide strategic support and guidance to the company by joining the board of directors effective January 1, 2025.
Since 2015, Keith has been instrumental in shaping MediPharm Labs into a pioneering force in the cannabis industry. His notable achievements include co-founding the first extraction-only cannabis company, overseeing the Company's successful acquisition and integration of VIVO Cannabis Inc., and leading MediPharm Labs to become the first commercial cannabis company in Canada to receive Good Manufacturing Practice ("GMP") site registration from the United States Food and Drug Administration (US FDA).
MediPharm Labs remains committed to its mission of providing high-quality, innovative cannabis solutions globally and ensuring the highest standards of production and compliance. The company will continue to focus on growing internationally, while maintaining its strong debt free balance sheet and enhancing profitability.
